Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Tables)

v3.19.1
Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2018
Accrued Liabilities, Current [Abstract]  
Schedule of Accrued Expenses and other payables

Accrued expenses consist of the following at:


 

 

December 31,

 

 

 

2018

 

 

2017

 

 

  

 

 

 

 

  

Accrued clinical trial expenses

 

$

919,750

 

 

$

1,504,240

 

Compensation and related benefits

 

 

628,147

 

 

 

542,434

 

Patent fees

 

 

40,000

 

 

 

40,000

 

Deferred rent

 

 

7,854

 

 

 

27,457

 

Other expenses

 

 

82,300

 

 

 

162,300

 

 

 

$

1,678,051

 

 

$

2,276,431